Cargando…
Comparison of platform technologies for assaying antibody to Ebola virus
BACKGROUND: The recent Ebola outbreak in West Africa led to the use of a variety of different platform technologies for assaying antibodies because of the difficulties of handling the live virus. The same types of method could be applied rapidly to other infections when they emerge. There is a need...
Autores principales: | Wilkinson, Dianna E., Page, Mark, Mattiuzzo, Giada, Hassall, Mark, Dougall, Thomas, Rigsby, Peter, Stone, Lindsay, Minor, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322821/ https://www.ncbi.nlm.nih.gov/pubmed/28161420 http://dx.doi.org/10.1016/j.vaccine.2016.11.083 |
Ejemplares similares
-
Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody
por: Mattiuzzo, Giada, et al.
Publicado: (2019) -
Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based Assays
por: Mattiuzzo, Giada, et al.
Publicado: (2015) -
Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus
por: Harvey, Ruth, et al.
Publicado: (2019) -
Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins
por: Bissett, Sara L., et al.
Publicado: (2014) -
WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community
por: Knezevic, Ivana, et al.
Publicado: (2022)